However, when comparing IDO1 inhibition to dual inhibition (red line), it was evidenced that dual inhibition was more potent than selective IDO1 inhibition alone in reducing tumor growth and tumor weight of CR tumors (Fig. 4A, B—red). The gene discussed is IDO1; the disease is neoplasm.